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Abstract 
Background: Lymphopenia promotes naïve T-cell homeostatic proliferation and adoptive effector T-cell survival 
and memory formation. IL-7 plays a critical role in homeostatic proliferation, survival and memory formation of naïve 
T-cells in lymphopenia, and its underlying molecular mechanism has also been well studied. However, the mechanism 
for adoptively transferred effector T-cell survival and memory formation is not fully understood. Here, we transferred 
in vitro-activated transgenic OT-I CD8+ effector T-cells into irradiation (600 rads)-induced lymphopenic C57BL/6, 
IL-7 knockout (KO) and IL-15 KO mice, and investigated the survival and memory formation of transferred T-cells in 
lymphopenia.
Results: We demonstrate that transferred T-cells prolong their survival and enhance their memory in lymphopenic 
mice, in a manner that depends on IL-15 signaling, but not IL-7. We determine that in vitro stimulation of naïve or 
effector T-cells with IL-7 and IL-15 reduces IL-7Rα, and increases and/or maintains IL-15Rβ expression, respectively. 
Consistent with these findings, the expression of IL-7Rα and IL-15Rβ is down- and up-regulated, respectively, in vivo 
on transferred T-cells in an early phase post T-cell transfer in lymphopenia. We further show that in vitro IL-15 restimu-
lation-induced memory T-cells (compared to IL-2 restimulation-induced effector T-cells) and in vivo transferred T-cells 
in irradiated IL-15-sufficient C57BL/6 mice (compared to IL-15-deficient IL-15 KO mice) have increased mitochondrial 
content, but less NADH and lower mitochondrial potential (ΔΨm), and demonstrate greater phosphorylation of signal 
transducers and activators of transcription-5 (STAT5) and Unc-51-like kinase-1 (ULK1), and higher expression of B-cell 
leukemia/lymphoma-2 (Bcl2) and memory-, autophagy- and mitochondrial biogenesis-related molecules.
Conclusion: Irradiation-induced lymphopenia promotes effector T-cell survival via IL-15 signaling the STAT5/Bcl2 
pathway, enhances T-cell memory formation via IL-15 activation of the forkhead-box family of transcription factor 
(FOXO)/eomesodermin (Eomes) memory and ULK1/autophagy-related gene-7 (ATG7) autophagy pathways, and via 
IL-15 activation of the mitochondrial remodeling. Our data thus identify some important targets to consider when 
designing potent adoptive T-cell immunotherapies of cancer.
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Background
Throughout life, T lymphocytes are maintained at 
fairly stable numbers by two distinct mechanisms, the 
activation-induced cell death (AICD) and the homeo-
stasis. AICD results in the removal of a large number of 
active lymphocytes after massive antigen-induced clonal 
expansion [1]. The level of peripheral naive and memory 
T-cell pools is under tight homeostatic control, which 
is critical to the maintenance of both a polyclonal rep-
ertoire of naïve T-cells capable of responding to newly 
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encountered pathogens, and a small population of anti-
gen-experienced memory T (Tm) cells that provide pro-
tection against previously encountered pathogens [2].
T-cell homeostasis can be severely perturbed by fac-
tors such as ionizing radiation, which leads to large scale 
loss of naïve T or effector T (Te) cells due to apoptosis 
[3], and further results in transient or sustained lym-
phopenia [4]. During recovery from T-cell depletion, 
adoptive naïve T-cells are driven into cell division. This 
process known as homeostatic proliferation, replen-
ishes the T lymphocyte pool [5], and leads to formation 
of CD44+CD62LhighIL-7R+ memory-like Tm cells [6–8]. 
IL-7 is critical for homeostatic proliferation, survival and 
memory formation of adoptive naive T-cells in lympho-
penia, and its underlying molecular mechanism has also 
been well studied [9, 10] However, the molecular cell-
intrinsic mechanism for the prolonged survival and the 
enhanced memory formation of adoptive Te cells in lym-
phopenia has not been fully described.
In this study, we established an irradiation-induced 
lymphopenic animal model by irradiating C57BL/6 
(B6) mice with 600  rads. Initially, we in  vitro activated 
CD8+ T-cells purified from Ovalbumin (OVA)-specific 
T-cell receptor (TCR) transgenic OT-I mice with OVA I 
(OVA257-264) peptide and IL-2, and transferred the result-
ing Te cells into irradiation-induced lymphopenic B6, 
IL-7 knockout (KO) and IL-15 KO mice. T-cell survival 
and memory formation were quantified in these lym-
phopenic mice by flow cytometry, Western blotting and 
confocal microscopy analyses. We demonstrated that 
transferred Te cells exhibited prolonged survival and 
enhanced memory formation during lymphopenia, and 
that IL-15 signaling is central to the observed proper-
ties of transferred T-cells. Our experiments revealed 
that IL-15Rβ and IL-7Rα expression was up- and down-
regulated, respectively, on transferred Te cells in an early 
phase post T-cell transfer in lymphopenia. Our work also 
showed that in  vitro IL-15 restimulation-induced Tm 
cells (compared to IL-2 restimulation-induced effector 
T-cells) and in  vivo transferred T-cells in irradiated IL-
15-sufficient B6 mice (compared to IL-15 deficient IL-15 
KO mice) had increased mitochondrial content, but less 
NADH and lower mitochondrial potential (ΔΨm), and 
demonstrated greater phosphorylation of signal trans-
ducers and activators of transcription-5 (STAT5) and 
Unc-51-like kinase-1 (ULK1), and higher expression 
of B-cell leukemia/lymphoma-2 (Bcl-2) and memory-, 
autophagy- and mitochondrial biogenesis-related mol-
ecules. Taken together, our data demonstrate that irra-
diation-induced lymphopenia promotes effector T-cells 
survival via IL-15 signaling the STAT5/Bcl-2 pathway, 
and enhances T-cell memory formation via IL-15 acti-
vation of the forkhead box (FOXO)/Eomesodermin 
(Eomes) memory and ULK1/autophagy-related gene 
7 (Atg7) autophagy pathways and the mitochondrial 
remodeling.
Results
Irradiation‑induced lymphopenia promotes naïve T‑cell 
homeostatic proliferation
Irradiation can induce the large scale loss of naïve T-cells 
[11, 12], thereby leading to lymphopenia in irradiated 
mice [4]. Accordingly, one day after irradiating WT 
B6 mice with 50, 200 or 600  rads, we observed a dose-
dependent depletion of naïve T-cells (Fig. 1a). To assess 
the potential for homeostatic proliferation of T-cells, we 
injected CFSE-labeled naïve CD8+ T-cells into B6 mice 
irradiated with 600 rads. Six days after T-cell transfer, we 
demonstrated that adoptive naïve T-cells are driven into 
homeostatic proliferation during recovery from T-cell 
depletion (Fig. 1b) [5], thus mice irradiated with 600 rads 
are lymphopenic.
Lymphopenia promotes effector T‑cell survival 
via up‑regulation of anti‑apoptotic Bcl‑2 
and down‑regulation of pro‑apoptotic Bax and Bcl‑Xs
To initiate the experiment, we activated OT-I CD8+ 
T-cells in  vitro by treating them with OVA I peptide 
and IL-2 for 4  days, and then phenotypically character-
ized them by flow cytometry. We demonstrated that 
these in  vitro-activated CD8+ T-cells lacked expression 
of memory marker IL-7R, but expressed active T-cell 
markers CD25 and CD69, the effector T (Te) cell mark-
ers IFN-γ and KLRG1, and the Te cell transcription factor 
T-bet (Fig.  2a), indicating that they are indeed bonafide 
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Fig. 1 Irradiation-induced lymphopenia promotes homeostatic 
proliferation of naïve T-cells. a Irradiation induces lymphopenia in 
mice. B6 mice (n = 6) were irradiated at different doses. One day 
later, the total numbers of lymphocytes in spleen were measured. b 
Proliferation profiles of naïve CD8+ T-cells in lymphopenic mice and 
WT B6 mice. Naïve CD8+ T-cells labeled with CFSE were injected intra-
venously (i.v.) into irradiated (600 rads) B6 or WT B6 mice. Splenocytes 
were collected 6 days post T-cell transfer, stained with PE-ani-CD8 Ab, 
and then analyzed by flow cytometry. The CD8/CFSE double positive 
T-cells were gated for observation of divisions of CFSE-labeled T-cells. 
One representative experiment of three is shown
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Te-cells in  vivo, we transferred these Te-cells into B6 
mice irradiated with different doses, and quantified the 
survival of OVA-specific CD8+ T-cells in peripheral 
blood by flow cytometry 6, 15 and 30  days post T-cell 
transfer. We found that the survival of transferred CD8+ 
T-cells in irradiated B6 mice was significantly prolonged, 
in a manner that depends on irradiation doses (50, 200 
and 600  rads), compared to WT B6 mice, in which the 
transferred T-cells declined dramatically (Fig. 2b, c). We, 
therefore, selected an irradiation dose of 600  rads for 
inducing lymphopenia in this study. To assess the mecha-
nism for prolonged survival, we measured expression of 
apoptosis-associated molecules by Western blot analysis. 
We demonstrated that there was fivefold increase in the 
abundance of the anti-apoptotic factor Bcl-2, and twofold 
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Fig. 2 Irradiation-induced lymphopenia promotes survival and memory formation of transferred effector T-cells. a In vitro OVA-I peptide/IL-2 
stimulated OT-I CD8+ T-cells were stained with various Abs (solid lines) and analyzed by flow cytometry. Gray shaded histograms represent isotype Ab 
controls. b Blood samples in WT B6 or irradiated (600 rads) B6 mice (n = 4) were collected and stained with PE-Kb/OVA I-tetramer (OVA-tetramer), 
FITC-anti-CD8 Ab (FITC-CD8), and analyzed by flow cytometry at indicated times after T-cell transfer. The values represent the percentages of OVA-
specific CD8+ T-cells in total CD8+ T-cell population. The values in parenthesis represent SD. c Kinetic assessment of transferred CD8+ T-cells in 
B6 mice irradiated with different doses by cytometry as described in (b). d Western blot analysis. Transferred T-cells were purified from WT B6 and 
irradiated (600 rads) B6 mice 6 days after T-cell transfer, and lysed for Western blot analysis. Relative expression represents the ratio of expression 
of each molecule in cells from irradiated B6 mice versus that in untreated control WT B6 mice. *p < 0.05, **p < 0.01. e, f Blood samples in irradiated 
(600 rads) B6 mice were collected and stained with PE-Kb/OVAI-tetramer, FITC-anti-CD8 Ab and PE-Cy5-Abs specific for various molecules, and 
analyzed by flow cytometry at indicated times after T-cell transfer. The double positive (OVA-tetramer and CD8) T-cells were gated as in Fig. 2b for 
assessing the expression of CD25, CD69, CD44, CD62L and IL-7R (solid lines). Gray shaded histograms represent isotype Ab controls. One representa-
tive experiment of two is shown
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factors Bcl-Xs and Bax in transferred CD8+ T-cells of 
irradiated B6 mice, compared to WT B6 mice (Fig. 2d).
Lymphopenia also enhances T‑cell memory formation
We then addressed whether T-cells transferred into WT 
B6 and irradiated B6 mice exhibited any differences with 
respect to memory phenotype by flow cytometry. Flow 
cytometry analyses demonstrated that the transferred 
T-cells gradually up-regulated expression of memory 
marker IL-7R, while rapidly down-regulating active T-cell 
markers CD25 and CD69 at day 6 and 15 post T-cell 
transfer (Fig. 2e). After 30 days, when transferred T-cells 
become long-term memory T (Tm) cells [13], they did 
express Tm cell markers CD44, IL-7R and CD62L as well 
as Tm cell transcription factor Eomes, but lacked expres-
sion of active and effector T-cell markers CD25, CD69, 
KLRG1 and T-bet in irradiated B6 mice (Fig. 2e, f ) and in 
WT B6 mice (data not shown). In addition, detected Tm 
cells (64 %) in irradiated B6 mice were much higher than 
those (2 %) in WT B6 mice (Fig. 2b), indicating that irradi-
ation-induced lymphopenia promotes Tm cell formation.
IL‑15 plays an important role in promoting T‑cell survival 
and memory in lymphopenia
The prolonged T-cell survival in lymphopenic mice may 
arise from microenvironment homeostasis, related to 
decreased competition for T-cell homeostatic cytokines 
such as IL-7 and IL-15 [14]. To address this possibility, we 
transferred the in vitro-activated OT-I CD8+ Te cells into 
irradiated (600 rads) WT B6, IL-7 KO and IL-15KO mice, 
followed by monitoring kinetics of their survival and 
memory formation. Consistent with our previous results 
(Fig. 2b), we showed that most (91 and 80 %) of T-cells 
transferred into irradiated WT B6 mice remained viable 
at day 6 and 15, and eventually became Tm-cells (60 %) 
at day 30 post T-cell transfer (Fig. 3a). T-cell survival and 
memory formation were only slightly affected by deple-
tion of IL-7 in irradiated IL-7 KO mice (Fig. 3a). In con-
trast, only 53 and 28 % of transferred T-cells survived at 
day 6 and 15, and only 18 % of transferred T-cells became 
Tm cells at day 30 post T-cell transfer in irradiated IL-15 
KO mice (Fig. 3a). It was previously reported that IL-15 
plays an important role in KLRG1hiIL-7Rαlo effector CTL 
survival and memory formation in WT mice [15]. Col-
lectively, our findings indicate that IL-15 signaling is also 
crucial for prolonged T-cell survival and enhanced T-cell 
memory formation in lymphopenic mice.
Transferred Te cells up‑regulate IL‑15Rβ, 
but down‑regulate IL‑7Rα expression early on post T‑cell 
transfer in lymphopenia
To assess a potential mechanism by which IL-15 contrib-
utes to the prolonged survival and enhanced memory of 
transferred T-cells, we first isolated naïve CD8+ T-cells 
from transgenic OT-I mice, and then measured IL-7Rα 
and IL-15Rβ expression in response to in  vitro stimula-
tion with OVA I peptide and IL-7 or IL-15. We found 
that IL-7 stimulation dramatically down-regulated 
IL-7Rα, but gradually up-regulated IL-15Rβ expres-
sion (Fig.  3b). In contrast, treatment of IL-15 gradually 
up-regulated IL-15Rβ, but dramatically down-regulated 
IL-7Rα expression in T-cells (Fig. 3b). We next assessed 
the stimulatory effect of IL-7 and IL-15 on Te cells, thus 
mimicking the situation of our study of the in vivo effect 
of IL-15 signaling on transferred Te cells in lymphopenia. 
In vitro OVAI/IL-2-stimulated OT-I Te cells were further 
cultured in medium containing IL-7 or IL-15, and the 
expression of IL-7Rα and IL-15Rβ was quantified by flow 
cytometry. Interestingly, we found that co-culture with 
IL-7 down-regulated the expression of IL-7Rα, whereas 
expression of IL-15Rβ in re-stimulated T-cells was rela-
tively unchanged upon treatment of IL-15 (Fig.  3c). To 
further investigate the differential contribution of IL-15 
relative to IL-7 with respect to the prolonged survival 
and enhanced memory of transferred T-cells in lympho-
penia, we isolated naïve CD8+ T-cells from transgenic 
OT-I mice, stimulated them with OVA I peptide and 
IL-2 for 4  days, transferred them into WT B6 and irra-
diated B6 mice, and quantified changes in the expression 
of IL-7Rα and IL-15Rβ over time. We found that trans-
ferred T-cells did not express any IL-7Rα and IL-15Rβ 
on day 1 post T-cell transfer in both WT and irradiated 
B6 mice (Fig.  3d). Interestingly, however, transferred 
T-cells in irradiated B6 mice expressed less IL-7Rα, but 
more IL-15Rβ, 3  days post T-cell transfer, when com-
pared to WT B6 mice (Fig. 3d). In addition, we found that 
IL-15Rα which was downregulated in IL-15 treated cells 
in vitro (Fig. 3c) was upregulated in the transferred effec-
tor T-cells in lymphopenic mice compared to WT mice 
(Additional file  1: Figure S1a). The upregulation may 
result from the released IL-15Rα from DCs or mono-
cytes after irradiation. We also found that the expression 
of IL-15Rα increased in effector T-cells co-cultured with 
irradiated DC in vitro (Additional file 1: Figure S1b).
In vitro IL‑15‑restimulated T‑cells become memory‑like 
Tm cells with prolonged survival and enhanced memory 
formation following their transfer into B6 mice
We next sought to assess the effect of in vitro IL-15 stim-
ulation on T-cell survival and memory formation in vivo, 
we first isolated naïve CD8+ T-cells from transgenic OT-I 
mice, and stimulated them with OVA I peptide and IL-2 
for 3 days, and then co-cultured them with IL-2 or IL-15 
for 4  days [16] prior to intravenous injection of them 
into B6 mice (Fig. 4a). We found that unlike the IL-2 re-
stimulation-induced effector T (short term: IL-2 Te) cells, 
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which expressed KLRG1, IL-15 stimulated T-cells did 
not, and instead up-regulated expression of the memory 
T-cell markers IL-7R and CD62L (Fig. 4b). These findings 
indicate that in  vitro IL-15 stimulated T-cells became 
IL-7R+CD62LhighKLRG1− memory-like Tm (short term: 
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Fig. 3 IL-7 and IL-15 distinctly modulate expression of IL-7Rα and IL-15Rβ. a Mouse blood samples were analyzed by flow cytometry at indicated 
times after T-cell transfer. The percentages of transferred OT-I CD8+ T-cells in the total CD8+ T-cell population were assessed. b Naïve OT-I CD8+ 
T-cells cultured in medium containing OVA I peptide and IL-7 or IL-15 (10 ng/ml) were analyzed by flow cytometry at indicated times. Relative 
expression represents the ratio of mean fluorescence intensity (MFI) for expression of each molecule at indicated time points versus that at the 
beginning (0 h) in naïve T-cells. c Naïve OT-I CD8+ cells were activated in complete medium containing OVA I peptide and IL-2 for 3 days, followed 
by starvation in complete medium without cytokine for 5 h. The resulting cells were further in vitro re-stimulated with IL-7 or IL-15 (10 ng/ml). 
The re-stimulated T-cells were then analyzed by flow cytometry. Relative expression represents the ratio of MFI for expression of each molecule at 
indicated time points versus that at the beginning (0 min) in effector T-cells. d Blood samples (n = 4) analyzed by flow cytometry at indicated days. 
The double positive (OVA-tetramer and CD8) T-cells were gated for further assessing the expression of IL-7Rα and IL-15Rβ (solid lines). Gray shaded 
histograms represent isotype Ab controls. Relative expression represents the ratio of MFI for the expression of each molecule at indicated time 
points in transferred effector T-cells post T-cell transfer versus that in effector T-cells before T-cell transfer. *p < 0.05, *p < 0.01. One representative 
experiment of three is shown
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their capacity for prolonged survival and vigorous recall 
responses upon antigen re-encounter [17]. We trans-
ferred IL-2 Te cells and IL-15 Tm cells into WT B6 mice 
to directly assess their memory T-cell characteristics 
(Fig. 4a). Compared to IL-2 Te cells, IL-15 Tm cells exhib-
ited prolonged survival and enhanced memory formation 
(Fig. 4c). To confirm these findings, we boosted mice with 
DCOVA, and measured recall responses by flow cytometry 
4 days after the boost. Indeed, we found roughly a sixfold 
increase of OVA-specific T-cells (Fig. 4c), indicating that 
these Tm cells are all functional.
In vitro IL‑15 signaling converts Te cells to Tm cells 
by altering the expression of key regulators of gene 
expression and autophagy and the number and functional 
properties of mitochondria
To dissect molecular pathways regulating in  vitro IL-15 
restimulation-induced prolonged T-cell survival and 
enhanced T-cell memory formation, we measured the 
expression of molecules controlling T-cell apoptosis, 
memory and autophagy, and the content of mitochondria 
(Fig. 4a). Compared to IL-2 Te cells, IL-15 Tm cells up-
regulated the expression of anti-apoptotic factor Bcl-2, 
increased the expression of the memory T-cell transcrip-
tion factors FoxO1 and Eomes, the autophagy-related 
molecules Atg7 and lysosomal acid lipase (LAL), and 
the 39 kDa structural subunit of complex-I of the mito-
chondrial electron transport chain (ETC) and enhanced 
the phosphorylation of ULK1 (pULK1) (Fig.  4d). Flow 
cytometry with MitoTracker Green, which binds to mito-
chondrial lipid membranes independent of their poten-
tial [18], demonstrated that the content of mitochondria 
was higher in IL-15 Tm cells than in IL-2 Te cells (Fig. 4e, 
f ). To complement these analyses, we also measured 
mitochondrial membrane potential (ΔΨm) represented 
by tetramethylrhodamine ester (TMRM) staining, and 
found that it was lower in IL-15 Tm cells (Fig. 4e). Finally 
because NADH is generated by the tricarboxylic acid 
(TCA) cycle and donates its electrons to complex-I, a 
core component of the mitochondrial oxidative phospho-
rylation (OXPHOS) system responsible for aerobic ATP 
production [19], we quantified the amount of NAD(H) 
(total NAD  +  and NADH) (Fig.  4a). We observed that 
IL-15 Tm cells had less NADH, as demonstrated by 
a lower amount of total NAD(H) and a higher NAD/
NADH ratio than IL-2 Te cells (Fig. 4g). Collectively, our 
data indicate that in vitro IL-15 signaling is able to con-
vert Te cells to Tm-cells by up-regulating the expression 
of Bcl-2, FOXO1, Eomes, Atg7, ETC-protein complex-1 
and LAL, increasing phosphorylation of ULK1, and 
enhancing mitochondrial biogenesis.
In vivo transferred T-cells up-regulate expres-
sion of Bcl-2, FoxO1, Eomes and Atg7, enhance the 
phosphorylation of pSTAT5 and ULK1 and activate 
the mitochondrial biogenesis via IL-15 signaling in 
lymphopenia.
To assess whether the above conclusion derived from 
our in vitro studies is relevant to the observed prolonged 
T-cell survival and enhanced T-cell memory in the lym-
phopenia model, we analyzed the expression of molecules 
controlling T-cell apoptosis, memory and autophagy in 
transferred T-cells. We demonstrated that transferred 
T-cells with prolonged survival up-regulated the expres-
sion of Bcl-2, FOXO1, Eomes and Atg7 to a greater 
extent, and enhanced the phosphorylation of STAT5 and 
ULK1 in irradiated B6 mice expressing IL-15 (Fig. 5a). In 
addition, we showed that transferred T-cells in irradiated 
B6 mice had a greater number of mitochondria (Fig. 5b) 
that were more tightly packed (Fig.  5c), and had lower 
mitochondrial membrane potential (ΔΨm) (Fig.  5b), 
when compared to those purified from irradiated IL-15 
deficient IL-15 KO mice. These findings provide further 
evidence that IL-15 signaling is a critical regulator essen-
tial for T-cell biology in lymphopenia.
Discussion
In this study, we generated an irradiation-induced lym-
phopenic mouse model. To assess a potential effect of 
lymphopenia on Te cells, we transferred active OT-I 
CD8+ T-cells into WT B6 or irradiated B6, and dem-
onstrate that irradiation (600  rads)-induced lymphope-
nia promotes Te cell survival and Tm cell formation. To 
assess whether IL-7 or IL-15 plays a major role in these 
effects, we transferred active OT-I CD8+ T-cells into irra-
diated B6, IL-7 KO and IL-15 KO mice. We demonstrate 
that transferred T-cells gradually up-regulate IL-7Rα and 
IL-15Rβ expression in both WT and irradiated B6 mice, 
and the prolonged survival and enhanced memory are 
mildly reduced in irradiated IL-7 deficient IL-7 KO mice, 
consistent with a previous report [20], but dramatically 
decreased in irradiated IL-15 deficient IL-15 KO mice. 
Collectively, our results indicate that IL-15 is important 
for the survival and memory formation of transferred Te 
cells in lymphopenic mice, in comparison to previously 
reported IL-7 that plays a critical role in homeostatic 
proliferation, survival and memory formation of adoptive 
naive T-cells in lymphopenia [9, 10].
To begin to address why IL-15 figures more promi-
nently than IL-7 in T-cell reprogramming in lymphope-
nia though both of them are of similar functional effects 
[21], we first assessed changes in expression of IL-7Rα 
and IL-15Rβ on naïve T-cells or Te cells following in vitro 
stimulation with IL-7 or IL-15. Consistent with a previ-
ous report [22], we found that IL-7 treatment down-
regulates IL-7Rα expression, while co-culture with IL-15 
either up-regulates IL-15Rβ expression on stimulated 
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“naïve” T-cells or maintains IL-15Rβ expression on 
IL-15-restimulated Te cells. We next extended these 
in vitro analyses, and reveal, for the first time, a distinct 
in  vivo modulation of IL-7Rα and IL-15Rβ expression 
on transferred Te cells in lymphopenia. We determine 
that IL-7Rα expression is transitionally down-regulated, 
whereas IL-15R expression is up-regulated in the early 
phase post T-cell transfer in lymphopenic mice. It is well-
known that irradiation removes the sinks for homeosta-
sis cytokines such as IL-7 and IL-15 [23] leading to IL-7 
and IL-15 increase in lymphopenia [24, 25], and induces 
radiation-sensitive hematopoietic cell apoptosis, lead-
ing to releasing its IL-15Rα and subsequent formation of 
IL-15/IL-15Rα complexes [26, 27]. As such, IL-15 in the 
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form of IL-15/IL-15Rα complexes thus becomes abun-
dant in the host after irradiation. It is therefore tempting 
to speculate that transferred T-cells receive pro-survival 
cytokine stimulation mainly derive from IL-15, but not 
IL-7, in early phase post T-cell transfer, because IL-15Rβ 
expression is up-regulated and soluble IL-15/IL-15Rα 
complexes provide very sensitive and potent IL-15 signal-
ing via binding of IL-15/IL-15Rα complexes to IL-15Rβ 
on transferred T-cells [27, 28]. This would provide a 
plausible mechanistic explanation for a dominant role for 
IL-15 in prolonged T-cell survival and enhanced Tm cell 
formation of transferred Te cells in lymphopenia.
T-cell apoptosis is to a large extent governed by members 
of the Bcl-2 family [29] composed of both pro- and anti-
apoptotic molecules [30]. Over-expression of anti-apoptotic 
Bcl-2 inhibits Te cell death [31], whereas over-expression 
of pro-apoptotic Bcl-Xs and Bax accelerate T-cell apoptosis 
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Fig. 5 In vivo IL-15 signaling converts transferred effector T-cells to memory-like Tm cells in lymphopenia. a Irradiated (600 rads) B6 and IL-15 KO 
mice (n = 4) were transferred with OT-I effector T-cells (20 × 106). Six days after transfer, splenocytes were stained with OVA-tetramer, PE-CY5-anti-
CD8 Ab and FITC-Abs specific for pSTAT5, Bcl-2, FOXO1, Eomes, pULK1 and Atg7, and analyzed by flow cytometry. The double positive (OVA-
tetramer and CD8) T-cells were gated for assessing the expression of various molecules in irradiated B6 mice (solid lines) and in irradiated IL-15 KO 
mice (dotted lines). Gray shaded histograms represent isotype Ab controls. MFI for expression of each molecule is shown. *p < 0.05, **p < 0.01. b 
Transferred OVA-specific T-cells in irradiated B6 and IL-15 KO mice were purified from spleens, 6 days post T-cell transfer, with PE-conjugated H-2 Kb/
OVA257–264 tetramer and anti-PE-microbeads, stained with MitoTracker and TMRM, and then analyzed by flow cytometry (irradiated B6 mice, solid 
lines; IL-15 KO mice, gray shaded histograms). c Confocal images show transferred T-cells stained with Mitotracker (green) and Hoechst (blue); scale 
bars represent 5 μm. One representative experiment of three is shown
(See figure on previous page.) 
Fig. 4 In vitro IL-15 signaling converts effector T-cells to memory T-cells with prolonged survival and enhanced memory. a Schematic diagram of 
the experiment design. b OVAI/IL-2-activated OT-I CD8+ T-cells were restimulated with IL-2 or IL-15, and became IL-2 Te or IL-15 Tm cells. They were 
stained with Abs, and analyzed by flow cytometry (solid lines). Gray shaded histograms represent isotype Ab controls. The percentages of CD62L, 
IL-7Rα and KLRG1 positive cells were shown. c IL-2 Te and IL-15 Tm cells (20 × 106) were adoptively transferred into B6 mice (n = 4), and blood 
samples were collected at day 4, day 30, and day 34 [4 days post DCOVA (1 × 106) boost for recall responses] post T-cell transfer, and analyzed by flow 
cytometry. The value in each panel represents the percentage of OVA-specific (OVA-tetramer positive) CD8+ T-cells within the total CD8+ T-cell pop-
ulation. d Western blot analysis of IL-2 Te and IL-15 Tm cell lysates using Abs specific for FOXO1, Eomes, T-bet, Bcl-2, pULK1, Atg7, complex-I. Relative 
expression represents the ratio of the expression of each molecule in IL-15 Tm cells versus that in IL-2 Te cells. e IL-2 Te (gray shaded histograms) and 
IL-15 Tm cells (solid lines) were stained with MitoTracker and TMRM, and analyzed by flow cytometry for measurement of mitochondrial mass and 
mitochondrial membrane potential, respectively. f Confocal images show IL-2 Te and IL-15 Tm cells stained with Mitotracker (green) and Hoechst 
(blue); scale bars represent 5 μm. g NADH amount in IL-2 Te and IL-15 Tm cells. Relative amount of NAD(t) (total NAD+ and NADH) and NADH and 
NAD/NADH ratio measured in IL-15 Tm cells and in IL-2 Te cells are shown. *p < 0.05, **p < 0.01. One representative experiment of three is shown
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STAT5 is required to maintain Bcl-2 expression in Te cells 
for their survival [34]. In this study, we show that transferred 
T-cells with prolonged survival up-regulate expression of 
Bcl-2, but down-regulate Bax and Bcl-Xs in irradiated B6 
mice. We also demonstrate that transferred T-cells with 
prolonged survival in irradiated IL-15 sufficient B6 mice 
increase phosphorylation of STAT5 and up-regulate expres-
sion of Bcl-2, when compared to those in irradiated IL-15 
deficient mice, further arguing that irradiation-induced 
lymphopenia promotes T-cell survival via IL-15 stimulation 
of the STAT5/Bcl-2 pathway.
The FoxO1 transcription factor promotes T-cell survival 
[35] and memory [36] via up-regulating memory T-cell 
transcription factor Eomes [37], and inhibits the memory 
target of rapamycin complex-1 (mTORC1), leading to 
down-regulation of the Te cell transcription factor T-bet 
[37]. To assess the molecular pathway responsible for 
enhanced Tm cell formation in lymphopenia, we measured 
the expression of FOXO1 and Eomes, and demonstrate 
that in  vitro IL-15 Tm cells (compared to IL-2 Te cells) 
and in vivo transferred T-cells in IL-15 sufficient B6 mice 
(compared to those in IL-15 deficient mice) indeed up-
regulate the expression of FOXO1 and Eomes in an IL-15 
dependent manner, indicating that lymphopenia promotes 
Tm-cell formation via IL-15 activation of the FOXO/
Eomes memory pathway for memory programming.
CD8+ Te cells depend on glycolysis to provide energy 
for proliferation and effector functions, whereas Tm cells 
depend on lipid oxidation for maintenance of their sur-
vival and memory phenotype [38]. The catabolic activ-
ity of autophagy is essential for growth, proliferation and 
homeostasis of these cells [39]. In the immune system, 
autophagy-related molecules such as the serine/threo-
nine kinase ULK1, autophagy-initiating kinase Atg7 and 
LAL have been found to be essential for mitochondrial 
health, effector T-cell viability and CD8+ Tm cell forma-
tion [40–43]. In this study, we demonstrate a key role 
both in vitro and in vivo for IL-15 in enhancing the phos-
phorylation of ULK1 and up-regulating the expression 
of Atg7 and LAL, indicating that lymphopenia promotes 
Tm cell formation via IL-15 dependent activation of the 
ULK1/Atg7 autophagy pathway for maintenance of their 
memory metabolism.
Naïve T-cells mainly use mitochondrial oxidative 
phosphorylation (OXPHOS) and fatty acid oxidation 
(FAO) for energy in the form of ATP [44]. After antigen 
encounter, T-cells shift to glycolytic metabolism to sus-
tain proliferation and effector functions [45]. During Tm 
cell development, T-cells down-regulate glycolytic path-
ways and revert back to catabolic metabolism, by using 
mainly OXPHOS and FAO. They up-regulate mitochon-
drial biogenesis, resulting in an increased mitochondrial 
spare respiratory capacity (SRC) to promote long-term 
survival [46]. IL-15 is known to support SRC and pro-
motes the use of FAO for energy via enhanced mitochon-
drial biogenesis, leading to Tm cell development [47]. In 
this study, we find that Tm-cells stimulated with IL-15 
in  vitro and T-cells transferred into irradiated B6 mice 
expressing IL-15 have higher mitochondrial contents 
and increased abundance of a catalytic subunit of ETC 
protein complex-I important for Tm cell function [48]. 
NADH is generated by the tricarboxylic acid (TCA) cycle 
and donates electrons to complex-I as part of OXPHOS 
[19]. We show that IL-15 Tm cells have less NADH, but 
a higher NAD/NADH ratio than IL-2 Te cells, suggesting 
that IL-15 Tm cells preferentially use OXPHOS to gener-
ate energy. Mitochondrial membrane potential (ΔΨm) is 
a metabolic parameter that represents the proton motive 
force (Δp) across the inner membrane, and is an essen-
tial facet of aerobic ATP synthesis [38]. Interestingly, we 
also show that Tm cells stimulated with IL-15 in  vitro 
and T-cells transferred into irradiated B6 mice express-
ing IL-15 have lower ΔΨm, a newly discovered metabolic 
signature of decreased glycolysis and increased SRC for 
prolonged T-cell survival and memory formation [49].
Adoptive T-cell immunotherapy for cancer, which was 
based upon the adoptive transfer of in vitro active tumor-
specific CD8+ T-cells into cancer patients, previously 
achieved only some degree of success [50, 51], mostly due 
to their very short lifespan in  vivo [52, 53]. The recent 
development of adoptive T-cell therapy using T-cells 
transfected with chimeric antigen receptor containing 
an intra-cellular signaling domain has greatly improved 
survival of transferred tumor-specific T-cells in patients 
[54]. Interestingly, the lymphopenic conditions also sig-
nificantly enhanced the efficacy of adoptively transferred 
tumor-specific CD8+ T-cells by prolonging their survival 
leading to memory-like Tm cells [23, 55, 56], superior to 
in  vitro expanded Te cells in controlling tumor growth 
[57]. In addition, the exposure to IL-15 also promotes an 
optimal response of CD8+ Tm cells with rapid division 
following antigen re-counter, and enhanced protective 
capacity against tumor cells [58].
Conclusion
Taken together, our data demonstrate that irradiation-
induced lymphopenia promotes adoptive Te cell sur-
vival via IL-15 signaling the STAT5/Bcl-2 pathway, and 
enhances T-cell memory formation via IL-15 activation 
of the FOXO/Eomes pathway for memory programming 
and the ULK1/Atg7 autophagy pathway and via IL-15 
activation of the mitochondrial biogenesis for mainte-
nance of their memory metabolism. We believe that this 
novel information should have an important impact on 
designing potent adoptive T-cell immunotherapies of 
treating cancer.
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Methods
Antibodies and animals
The fluorescein isothiocyanate (FITC) anti-mouse Bcl-2 
antibody (Ab) was purchased from BD-Biosciences (Mis-
sissauga, Ontario, Canada). Mouse IL-15Rα biotinylated 
Ab was purchased from R&D system (Minneapolis, MN). 
The biotin-labeled Abs for IL-15Rβ (5H4) and KLRG1 
(2F1), the phycoerythrin (PE)-CY5-labeled Ab for CD8 
(53-6.7), PE-labeled Abs for Eomes (Dan11mag), IFN-γ 
(XMG1.2) and T-bet (eBio4B10), and PE-CY5 labelled 
streptavidin were purchased from eBiosciences (San 
Diego, CA). The biotin-labeled Abs for CD25 (7D4), CD44 
(IM7), CD62L (MEL-14), CD69 (H1.2F3), Ly6C (HK1.4) 
and IL-7Rα (SB/199) were purchased from Biolegend (San 
Diego, CA). Rabbit Ab for Atg7 and the mitochondrial 
complex-I structural subunit NDUFA9 (20C11B11B11) 
were purchased from Abcam (Cambridge, UK). Rab-
bit Abs for Bcl-2, Bax, Bcl-Xs, Eomes, T-bet and β-actin, 
mouse Ab for LAL (9G7F12) were purchased from Santa 
Cruz Biotechnology (Dallas, Texas, USA). Rabbit Abs for 
pULK1 (p-S467), FoxO1 and pSTAT5 (p-Y694) were pur-
chased from Cell Signaling Technology (Beverly, MA). 
PE-labeled H-2 Kb/OVA257–264 tetramer and FITC-labeled 
anti-CD8 (KT15) Ab were obtained from Beckman Coul-
ter (San Diego, CA). Ovalbumin (OVA) I peptide (OVA257–
264, SIINFEKL) specific for H-2  Kb was synthesized by 
Multiple Peptide Systems (San Diego, CA). The goat anti-
rabbit or mouse IRDyeR800CW Ab was purchased from 
LI-COR Bioscience (Lincoln, Nebraska). Female wild-type 
(WT) B6 mice, and OVA-specific TCR transgenic OT-I 
and IL-7 knockout (IL-7 KO) mice on B6 background 
were purchased from Jackson Laboratory (Bar Harbor, 
MA). IL-15 knockout (IL-15 KO) mice on B6 background 
were obtained from Taconic Biosciences (Rensselaer, NY). 
All mice were housed in the animal facility at the Health 
Sciences Building, and treated according to Animal Care 
Committee guidelines of University of Saskatchewan.
Activation of CD8+ T‑cell in vitro
Naive CD8+ T-cells were isolated from the spleens of 
transgenic OT-I mice, enriched by passage through nylon 
wool columns (C&A Scientific, Manassas, VA), and then 
fractionated by negative selection using anti-mouse CD4 
(L3T4) paramagnetic beads (DYNAL Inc., Lake Success, 
NY) according to the manufacturer’s protocols to yield 
T-cell populations that were ~95  % CD8+/Vα2  Vβ5. To 
generate active T-cells, CD8+ T-cells purified from OT-I 
mice were activated in complete RPMI medium contain-
ing 100 U/ml IL-2, 50 µM 2-mercaptoethanol (2-ME), and 
0.1  nM OVA-I peptide (SIINFEKL) for 3 or 4  days [47]. 
A portion of these active OT-I mouse CD8+ T-cells were 
intravenously (i.v.) transferred into irradiation-induced 
lymphopenic mice. The remainders were washed with PBS, 
and then further cultured in complete RPMI medium con-
taining either IL-2 (100 U/ml) or IL-15 (10 ng/ml) (Pepro-
tech, Rocky Hill, NJ) for an additional 4  days to generate 
in vitro IL-2-restimulated and in vitro IL-15-restimulatied 
T-cells. All cytokine-stimulated OT-I mouse CD8+ T-cells 
were analyzed by flow cytometry or lysed in RIPA lysing 
buffer (Thermo Scientific, Waltham, MA) containing both 
Halt Protease and Halt Phosphatase Inhibitor Cocktails 
(Thermo Scientific) for Western blot analysis.
In vivo CD8+ T‑cell survival and memory information
Wild-type and irradiated (600  rads) B6, IL-7 KO and 
IL-15 KO mice were i.v. transferred with the above 
in  vitro activated CD8+ T-cells (20  ×  106 cells per 
mouse). Tetramer staining assay was performed to exam-
ine the presence of OVA-specific CD8+ T-cells in mouse 
peripheral blood at day 6, 15, 30 post T-cell transfer. The 
tail blood samples were stained with PE-H-2 Kb/OVA257–
264 tetramer, FITC-anti-CD8, and some PE-CY5-antibod-
ies, respectively, and then analyzed by flow cytometry.
Dendritic cells preparation
Bone marrow-derived dendritic cells (DCs) were 
obtained by culturing bone marrow cells of WT B6 in 
culture medium containing granulocyte monocyte col-
ony-stimulating factor (GM-CSF) (20  ng/ml) and IL-4 
(20 ng/ml) (Peprotech) for 6 days as previously described 
[59]. DCs were pulsed with OVA (0.5  mg/ml) for over-
night and termed DCOVA.
Western‑blotting
Transferred OVA-specific CD8+ T-cells in mice were puri-
fied, 6 days post T-cell transfer, with PE-conjugated H-2 Kb/
OVA257–264 tetramer and anti-PE-microbeads (Miltenyi Bio-
tech, Auburn, CA) [60] and lysed in ice-cold RIPA lysing 
buffer. Equal amounts of cell lysates were loaded onto 12 % 
acrylamide gels (SDS-PAGE) and transferred onto nitrocel-
lulose membrane. The membrane was blocked with OYSSEY 
blocking buffer (LI-COR Bioscience), and immunoblotted 
with various antibodies polyclonal rabbit antibodies specific 
for Bax, Bcl-Xs and Bcl-2 at 4  °C for overnight. The mem-
brane was detected with goat anti-rabbit IRDyeR800CW and 
scanned under ODYSSEY instrument according to manu-
facturer’s instruction (LI-COR Bioscience). Band intensities 
were analyzed by using Image J software.
Flow cytometry for intracellular markers
WT B6 mice and irradiated (600 rads) B6, IL-7 KO 
and IL-15 KO mice were i.v. transferred with the above 
in  vitro activated OT-I CD8+ T-cells (20  ×  106 cells 
per mouse). Six days after T-cell transfer, mice tail 
blood were collected and stained with PE-Kb/OVAI-
tetramer and PE-Cy5-conjugated anti-CD8 Ab. After 
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permeabilization using Cytoperm™ Permeabilization 
Buffer (BD-Biosciences), cells were stained with FITC-
labeled anti-pSTAT5, anti-Bcl-2, anti-Eomes, anti-FoxO1 
and anti-Atg7 Abs, and then analyzed by flow cytometry.
Mitochondrial assays
The mitochondria mass and mitochondrial membrane 
potential (ΔΨm) were measured by MitoTracker Green (Life 
Technologies) and tetramethylrhodamine ester (TMRM), 
respectively, as previously described [61]. Briefly, in vitro IL-
2-restimulated and IL-15-restimulated T-cells were stained 
with MitoTracker Green at 50 nM or TMRM at 10 µM for 
15 min at 37 °C, respectively, according to the manufactur-
er’s manual. NAD(H) measurements were performed with 
the NAD+ and NADH Quantification kit (BioVision, Milpi-
tas, CA), according to the manufacturer’s manual.
Confocal microscopy
In vitro IL-2-restimulated and IL-15-restimulated T-cells 
or transferred OVA-specific CD8+ T-cells in irradiated 
B6 or IL-15 KO mice, which were purified, six days post 
T-cell transfer, with PE-conjugated H-2  Kb/OVA257–264 
tetramer and anti-PE-microbeads (Miltenyi Biotech), 
were stained with MitoTracker Green and TMRM, 
washed three times with PBS, and then incubated 
with 5  μg/ml of Hoechst 33342 (Life Technologies) for 
20 min at room temperature. Fluorescence images were 
acquired using the acquisition software FV1000 Version 
1 (FV10-ASW) on an inverted IX81 confocal microscope 
(FV1000) (Olympus, Shinjuku, Tokyo, Japan).
Statistical analysis
Unless stated otherwise, data are expressed as mean 
(with SD). Statistical analyses were performed using the 
Mann–Whitney U test for comparison of variables from 
different groups in animal studies or the Student t test 
for comparison of variables from different groups in all 
other studies. Probability values of p > 0.05, p < 0.05 and 
p < 0.01 are considered statistically not significant, signif-
icant and very significant, respectively.
Additional file
Additional file 1: Figure S1. Assessment of IL-15Rα expression. (a) 
Blood samples in WT B6 or irradiated B6 mice (n = 4) at day 5 post T-cells 
transfer were stained with OVA-tetramer, anti-CD8 Ab and anti-IL-15Rα Ab, 
and analyzed by flow cytometry. OVA-tetramer and CD8 double positive 
T-cells were gated for further assessing the expression of IL-15Rα (solid 
lines). Gray shaded histograms represent isotype Ab controls. **p < 0.01. 
(b) Naïve OT-I CD8+ cells were activated in complete medium containing 
OVA I peptide and IL-2 for 3 days, followed by co-culturing with or without 
irradiated (10,000 rads) bone marrow-derived DCs for another 16 h. The 
resulting cells were then stained with anti-CD8 Ab and anti-IL-15Rα Ab, 
and analyzed by flow cytometry. CD8 positive T-cells were gated for 
further assessing the expression of IL-15Rα. *p < 0.05. One representative 
experiment of three is shown.
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